The First Nations Health Authority (FNHA) is proud to announce a wellness initiative aimed at protecting pregnant individuals and their babies from Respiratory Syncytial Virus (RSV). For the 2025-2026 RSV season, FNHA is providing full coverage for the Abrysvo™ RSV vaccine for eligible pregnant individuals. This initiative ensures increased protection for both parent and baby.
Why RSV Protection Matters
RSV is a common seasonal virus that spreads easily through coughs, sneezes, and contact with surfaces. While it usually causes mild symptoms in adults, it can lead to serious complications in infants under six months, including bronchiolitis and pneumonia.
By taking action during pregnancy, you can help shield your baby from these risks.
FNHA’s Acting Chief Medical Officer Dr. Kelsey Louie says the best way to get answers to your questions about vaccines is to speak to somebody who knows you, your family, and your community.
Dual Protection with Abrysvo
The Abrysvo vaccine offers two layers of protection:
- For the pregnant parent: Strengthened immunity during RSV season.
- For the baby: Up to 57% reduction in hospitalization risk during their first RSV season.
Coverage Details
For the 2025-26 RSV Season, FNHA Health Benefits will cover the Abrysvo vaccine for pregnant individuals to receive it between 32 and 36 weeks of pregnancy. Pharmacies can submit an online claim through Pacific Blue Cross. Please contact FNHA Health Benefits at 1-855-0550-5454 with any coverage questions.
Note: system changes are underway to enable pharmacies to bill FNHA directly; if coverage is not yet available to you, please contact First Nations Health Benefits 1-855-550-5454.
Additional Infant Protection
Limited doses of the infant antibody Nirsevimab are also available through BC Children's Hospital for eligible infants. For those not eligible, the Abrysvo vaccine is a recommended alternative to help ensure your baby is protected.
Next Steps
Speak with your family doctor, nurse practitioner, community health nurse, or pharmacist to learn more about RSV protection options, including Abrysvo and Nirsevimab.
Together, we can take meaningful steps to safeguard the health of our children and communities.
